Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-583-1 | CAS number: 108-44-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- m-toluidine
- EC Number:
- 203-583-1
- EC Name:
- m-toluidine
- Cas Number:
- 108-44-1
- Molecular formula:
- C7H9N
- IUPAC Name:
- 3-methylaniline
- Details on test material:
- purity: 99 %
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- initial bw (females): 200-247 g
initial bw (males): 267-361g
acclimisation: 5 days
temperature of the animal room: 24 °C
relative humidity: 55 %
lighting 12 hours light 12 hours dark
food ad libitum,
water ad libitum
pregnant females should be caged individually
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- Dosing of both sexes should begin 2 weeks prior to mating, continued through mating period.
Males: dosing continued up to the day when females are killed.
Females. dosing continued throughout pregnancy and up to day 4 of lactation. - Details on mating procedure:
- One female to one male until pregnancy occurs; day 0 of pregnancy is defined as the day sperm is found.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Details not given.
- Duration of treatment / exposure:
- Males 42 days; females: from day 14 prior to mating to day 3 of lactation ( ca.42 days).
- Frequency of treatment:
- daily
- Details on study schedule:
- - Age at mating of the mated animals in the study: 10 weeks
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 30, 100, 300 mg/kg bw/day
Basis:
actual ingested
- No. of animals per sex per dose:
- 13
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- As requested by OECD TG 422.
- Positive control:
- No
Examinations
- Parental animals: Observations and examinations:
- At least once per day:
--behavioual changes , signs of difficult or prolonged parturition, mortality and all signs of toxicity
--cage side observations: changes in skin, fur, eyes, mucous membranes, respiratory, circulatory, autonomic and central nervous system function
--food cinsumption, males and females should be weighed
--duration of gestation, examination of the litter as soon as possible: number and sex of pups, stillbirth, live birth, pup weight, and the presence of ggross anomalies
clinical examinations: hematology, clinical chemistry, urinalysis
pathology: gross necropsy, histopathology - Oestrous cyclicity (parental animals):
- no data
- Sperm parameters (parental animals):
- no data
- Litter observations:
- PARAMETERS EXAMINED
The following parameters were examined in F1 offspring: Number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical or behavioural abnormalities.
GROSS EXAMINATION OF DEAD PUPS:
yes, for external abnormalities - Postmortem examinations (parental animals):
- Pathology: gross necropsy, histopathology
- Postmortem examinations (offspring):
- External malformation
- Statistics:
- yes, but methods not given
- Reproductive indices:
- number of mated pairs,
number of copulated pairs
copulation index,
number of pregnant animals,
fertility index,
pairing days undit copulation
implantation index
gestation index,
delivery index
- Offspring viability indices:
- number of pups born
number of pup alive
birth index
live birth index
sex ratio
number of pups alive on day 4
viability index
body weight of F1 pups up to day 4
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Other effects:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Details on results (P0)
no deaths occurred during the study,
clinical signs included: brownish urine, increased salivation in males and females receiving 100 mg/kg bw/day and more
BODY WEIGHT AND WEIGHT GAIN
mean body weight gain during week 1 of the 300 mg/kg bw/day males and of the 100 and 300 mg/kg bw/day females was significantly lower than those of the controls
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study)
mean food consumption of the 300 mg/kg bw/day males and females was significantly reduced at week 1
HAEMATOLOGY (significant changes only)
no female data were mentioned
males
in the 100 and 300 mg/kg bw/day males values for erythrocyte count, hemoglobin concentration and hematocrit were decreased and mean corpuscular volume was increased.
At 300 mg/kg bw/day males mean corpuscular hemoglobin was significantly increased, mean corpuscular hemoglobin concentration was decreased.At 300 mgU/kg bw/day: in the differential blood picture segmented neutrophils and monocytes were significantly reduced as well as lymphocytes and platelet count
CLINICAL CHEMISTRY
no female data were mentioned
males
in the 100 and 300 mg/kg bw/day males the A/G ratio, , serum bilirubin, potassium and chloride levels significantly increased with the dose
in the 300 mg/kg bw/day males significant increases in serum glucose and total cholesterol levels
in the 300 mg/kg bw/day males significant decreases inalbumin, phospherous and GOT levek NEUROBEHAVIOUR
low motor activity and pale extremities in males and females given 300 mg/kg bw/day
ORGAN WEIGHTS
relative kidney weights of the 300 mg/kg bw7day males and females were significantly greater than those of the controls
PATHOLOGY
HISTOPATHOLOGY: NON-NEOPLASTIC
--from30 mg/kg bw/day onwards a slight increase in severity of pigmentation or extramedullary hematopoiesis in the spleen in males and females were noted
--Pigment deposites and extramedullary hematopoiesis in the liver and spleen and congestion in the spleen in males and females that received 100 mg/kg bw/day and more.
--Swelling of hepatocytes in centrilobular zone in 100 mg/kg bw/day males and in the 300 mg/kg bw/day males and females;
--deposits of pigment in the renal tubular epithelium in 300 mg /kg bw/day males and females
--eosiophilic droplets in the renal tubular epithelium in males given 100 mg/kg bw/day and more;
--regenerated renal tubules in females given 100 mg/kg bw/day and more
--focal hyperplasia of epithelium in the urinary bladder in the 300 mg/kg bw/day males
no effects on copulation index
no effect on fertility index
no effect on gestation index up to 100 mg/kg bw/day
gestation lenght no effect up to 100 mg/kg bw/day
total implantation loss at 300 mg/kg bw/day
implantation loss in 2/10 pregnant females at 100 mg/kg bw
no effect of delivery index up to 100 mg/kg bw/day
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 30 mg/kg bw/day (actual dose received)
- Sex:
- male/female
- Basis for effect level:
- other: based on implantation losses in all animals at 300 mg/kg bw/day and in 2 of 10 at 100 mg/kg bw/day
- Dose descriptor:
- LOAEL
- Effect level:
- 30 mg/kg bw/day
- Sex:
- male/female
- Basis for effect level:
- other: Based on hemolytic anemia with deposit pigmentation and extramedulary hematopoiesis observed in all dosed rats
- Remarks on result:
- other: Generation: general toxicity
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- not specified
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not examined
Details on results (F1)
up to and including 100 mg/kg bw/day : no effect
CLINICAL SIGNS (OFFSPRING)
no findings mentioned
BODY WEIGHT (OFFSPRING)
up to day 4 of lactation: no effect
GROSS PATHOLOGY (OFFSPRING)
up to and including of 100 mg/kg bw/day no findings
OTHER FINDINGS (OFFSPRING)
live birth index : no effects
viability index: no effect
sex ratio: no effects
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 100 mg/kg bw/day (actual dose received)
- Sex:
- male/female
- Basis for effect level:
- other: no significant differences in the pup viability, pup weights and incidence of morphological abnormalities of pups
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Applicant's summary and conclusion
- Executive summary:
In the available OECD combined reated dose and reproductive /developmental toxicity screening study according to OECD TG 422 and GLP male and female rats received doses of 0, 30, 100 and 300 mg/kg bw/day 14 days before mating to 14 days after mating in males and for 14 days before mating to day 3 of lactation in females (MHLW 1995).
The LOAEL (general toxicity) is 30 mg/kg bw/day based on deposit pigmentation and extramedullary hematopoiesis in all examined animals (UNEP 2003). Reproductive organs were not affected by treatment.
No compound-related adverse effects were detected with regard to the mating performances at and dose levels. However, 2/10 pregnant females receiving 100 mg/kg bw/day and all eleven receiving 300 mg/kg bw/day showed total implant losses in utero. Therefore the NOAEL for reproductive toxicity is considered to be 30 mg/kg bw/day (UNEP 2003).
2/11 pregnant females receiving 30 mg/kg bw/day and 3/10 receiving 100 mg/kg bw/day did not show nursing activity obiously and 11 or more than half number of their pups died after birth, while all live offsprings of other dams in 30 and 100 mg/kg groups had normally developed up to 4 days. Therefore this death of pups is considered as a result of maternal toxicity, probably due to anemia. Furthermore, change of pup weights and incidence of morphologic abnormalities of pups were not significant in 30 and 100 mg/kg . The NOAEL for developmental toxicity is considered to be 100 mg/kg bw/day (UNEP 2003)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
